PAVmed Net Invested Capital from 2010 to 2024

PAVMZ Stock  USD 0.01  0.00  0.00%   
PAVmed Series Net Invested Capital yearly trend continues to be fairly stable with very little volatility. Net Invested Capital is likely to outpace its year average in 2024. Net Invested Capital is the total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents. View All Fundamentals
 
Net Invested Capital  
First Reported
2010-12-31
Previous Quarter
-12.6 M
Current Value
-12 M
Quarterly Volatility
17.5 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check PAVmed Series financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PAVmed Series' main balance sheet or income statement drivers, such as Interest Expense of 559.5 K, Selling General Administrative of 32.5 M or Other Operating Expenses of 74.8 M, as well as many indicators such as Price To Sales Ratio of 11.54, Dividend Yield of 3.0E-4 or Days Sales Outstanding of 14.05. PAVmed financial statements analysis is a perfect complement when working with PAVmed Series Valuation or Volatility modules.
  
Check out the analysis of PAVmed Series Correlation against competitors.

Latest PAVmed Series' Net Invested Capital Growth Pattern

Below is the plot of the Net Invested Capital of PAVmed Series Z over the last few years. It is the total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents. PAVmed Series' Net Invested Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in PAVmed Series' overall financial position and show how it may be relating to other accounts over time.
Net Invested Capital10 Years Trend
Pretty Stable
   Net Invested Capital   
       Timeline  

PAVmed Net Invested Capital Regression Statistics

Arithmetic Mean4,020,300
Geometric Mean4,357,935
Coefficient Of Variation434.67
Mean Deviation11,037,213
Median(1,936,739)
Standard Deviation17,475,096
Sample Variance305.4T
Range71.9M
R-Value0.26
Mean Square Error306T
R-Squared0.07
Significance0.34
Slope1,030,157
Total Sum of Squares4275.3T

PAVmed Net Invested Capital History

2024-12 M
2023-12.6 M
202221.3 M
202159.2 M
202014.3 M
2019M
20183.6 M

About PAVmed Series Financial Statements

PAVmed Series investors use historical fundamental indicators, such as PAVmed Series' Net Invested Capital, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in PAVmed Series. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Invested Capital-12.6 M-12 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for PAVmed Stock Analysis

When running PAVmed Series' price analysis, check to measure PAVmed Series' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PAVmed Series is operating at the current time. Most of PAVmed Series' value examination focuses on studying past and present price action to predict the probability of PAVmed Series' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PAVmed Series' price. Additionally, you may evaluate how the addition of PAVmed Series to your portfolios can decrease your overall portfolio volatility.